Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis

dc.contributor.authorKoksal, Muammer Osman
dc.contributor.authorPirkl, Martin
dc.contributor.authorSarsar, Kutay
dc.contributor.authorIlktac, Mehmet
dc.contributor.authorHoremheb-Rubio, Gibran
dc.contributor.authorYaman, Murat
dc.contributor.authorAgacfidan, Ali
dc.date.accessioned2026-02-06T18:24:39Z
dc.date.issued2024
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractHuman pegivirus (HPgV) is transmitted through sexual or parenteral exposure and is common among patients receiving blood products. HPgV is associated with lower levels of human immunodeficiency virus (HIV) RNA and better survival among HIV-infected patients. This study aimed to investigate the prevalence of HPgV and determine its subtypes in HIV-infected individuals living in Istanbul, which has the highest rate of HIV infection in Turkiye. Total RNA extraction from plasma, cDNA synthesis, and nested PCR were performed for HPgV on plasma samples taken from 351 HIV-1-infected patients. The HPgV viral load was quantified on HPgV-positive samples. HPgV genotyping was performed by sequencing the corresponding amplicons. In the present study, the overall prevalence of HPgV RNA in HIV-infected patients was 27.3%. HPgV subtypes 1, 2a, and 2b were found, with subtype 2a being the most frequent (91.6%). Statistical analysis of HIV-1 viral load on HPgV viral load showed an opposing correlation between HIV-1 and HPgV loads. In conclusion, these data show that HPgV infection is common among HIV-positive individuals in Istanbul, Turkiye. Further comprehensive studies are needed to clarify both the cellular and molecular pathways of these two infections and to provide more information on the effect of HPgV on the course of the disease in HIV-infected individuals.
dc.description.sponsorshipKoeln Fortune Program, Faculty of Medicine, University of Cologne
dc.description.sponsorshipNo Statement Available
dc.identifier.doi10.3390/v16010005
dc.identifier.issn1999-4915
dc.identifier.issue1
dc.identifier.orcid0000-0001-8411-2795
dc.identifier.orcid0000-0001-5944-0180
dc.identifier.orcid0000-0002-6487-102X
dc.identifier.orcid0000-0002-6986-0813
dc.identifier.orcid0000-0002-9529-9804
dc.identifier.orcid0000-0002-6564-9412
dc.identifier.pmid38275941
dc.identifier.scopus2-s2.0-85183446149
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/v16010005
dc.identifier.urihttps://hdl.handle.net/11129/10291
dc.identifier.volume16
dc.identifier.wosWOS:001151133300001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofViruses-Basel
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260204
dc.subjecthuman immunodeficiency virus (HIV)
dc.subjecthuman pegivirus (HPgV) prevalence
dc.subjectHIV/HPgV co-infection
dc.titleInterplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis
dc.typeArticle

Files